Digital Therapeutics for MCI and Alzheimer’s disease: A Regulatory Perspective — Highlights From The Clinical Trials on Alzheimer’s Disease conference (CTAD)

Detalles Bibliográficos
Autores principales: Shuren, J., Doraiswamy, P. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Point of View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920745/
https://www.ncbi.nlm.nih.gov/pubmed/35542995
http://dx.doi.org/10.14283/jpad.2022.28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920745/
https://www.ncbi.nlm.nih.gov/pubmed/35542995
http://dx.doi.org/10.14283/jpad.2022.28

Ejemplares similares